Public Profile

CITI PHARMA

CITI PHARMA, a leading pharmaceutical company headquartered in Pakistan, has established itself as a key player in the healthcare industry since its inception in 1994. With a strong operational presence across various regions, the company focuses on the development, manufacturing, and marketing of high-quality pharmaceutical products. CITI PHARMA is renowned for its diverse portfolio, which includes prescription medications, over-the-counter products, and specialised formulations. The company’s commitment to innovation and quality has earned it a reputable position in the market, marked by several key milestones in research and development. With a dedication to improving patient outcomes, CITI PHARMA continues to expand its reach and enhance its product offerings, solidifying its status as a trusted name in the pharmaceutical sector.

DitchCarbon Score

How does CITI PHARMA's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

22

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

CITI PHARMA's score of 22 is lower than 84% of the industry. This can give you a sense of how well the company is doing compared to its peers.

16%

Let us know if this data was useful to you

CITI PHARMA's reported carbon emissions

CITI PHARMA, headquartered in Pakistan (PK), currently does not have available data on carbon emissions, as no specific emissions figures have been reported. Consequently, there are no documented reduction targets or climate commitments outlined by the company. In the absence of concrete emissions data, it is essential to note that many companies in the pharmaceutical industry are increasingly focusing on sustainability and climate action. This often includes setting science-based targets for emissions reductions and committing to initiatives aimed at minimising their carbon footprint. However, without specific information from CITI PHARMA, it is unclear what their particular commitments or strategies may be in this regard.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. CITI PHARMA's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for CITI PHARMA is in PK, which has a medium grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

CITI PHARMA is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Haleon Pakistan Limited

PK
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Abbott Laboratories (Pakistan) Limited

PK
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

GlaxoSmithKline Pakistan Limited

PK
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers